GLENMARK:NSE
Glenmark Pharmaceuticals Ltd
₹2,283.00
arrow_downward
-0.44%(-10.00) 1D
Oct 12, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLENMARK...
Open
₹2,275.00
High
₹2,293.90
Low
₹2,252.00
Mkt. cap
644.32B
Avg. vol.
586.00K
Volume
695.53K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
35.85
52-wk high
₹2,537.60
52-wk low
₹1,792.60
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
Open
₹2,275.00
High
₹2,293.90
Low
₹2,252.00
Mkt. cap
644.32B
Avg. vol.
586.00K
Volume
695.53K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
35.85
52-wk high
₹2,537.60
52-wk low
₹1,792.60
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
News stories
From web sources and news partners
BigGo Finance
·
35 minutes ago
S&P 500 Bull Market Turns 4, AI Fuels 118% Surge—Rates Loom as Year 5 Hurdle
Stocktwits
·
59 minutes ago
Big Banks Kick Off Q3 Earnings With S&P 500 Near Records — Strategists Flag What Could Move Markets
BeInCrypto
·
1 hour ago
Less-Risky Treasuries Now Pay Better Than S&P 500 as Yield Spread Hits -1.5%
MercoPress
·
23 hours ago
S&P 500 Price Prediction: What Macro Signals Say About the Index in 2026
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd